bls_ilb_710c
Vaccineexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02195089)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearImmunity, active
Unclear immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bls_ilb_710c
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02195089 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2014 | BioLeaders Corporation, Catholic University of Korea, Keimyung University, Korea University, KwanDong University, University of Ulsan |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioLeaders Corporation | For profit | 1 | 1 | 1 | 2014 |
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Keimyung University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| KwanDong University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Ulsan | Academic/Hospital | 1 | 0 | 1 | 2014 |
6 organizations
Page 1 / 1